Author:
Höppner Wolfgang,Bach-Rojecky Lidija,Primorac Dragan
Publisher
Springer International Publishing
Reference26 articles.
1. Kirchheiner J, Brøsen K, Dahl ML, Gram LF, Kasper S, Roots I, et al. CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages. Acta Psychiatr Scand. 2001;104:173–92. https://doi.org/10.1034/j.1600-0447.2001.00299.x.
2. VeraCode® ADME Core Panel Assay Guide—Illumina. Available online: https://support.illumina.com/downloads/veracode_adme_core_panel_assay_guide_15007510.html. Accessed 12 Apr 2022.
3. Arbitrio M, Di Martino MT, Scionti F, Agapito G, Guzzi PH, Cannataro M, et al. DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine. Oncotarget. 2016;7:54028–50. https://doi.org/10.18632/oncotarget.9927.
4. ThermoFisher Scientific. Pharmacoscan Assay. Available online: https://www.thermofisher.com/order/catalog/product/903010TS. Accessed 10 Apr 2022.
5. Gabriel S, Ziaugra L, Tabbaa D. SNP genotyping using the Sequenom mass array iPLEX platform. Curr Protoc Hum Genet. 2:2–12. (2009). https://doi.org/10.1002/0471142905.hg0212s60.